Try our Advanced Search for more refined results
Health
- 
									September 22, 2025
									J&J Ruling Misapplied Goldman Precedent, 3rd Circ. ToldThe U.S. Chamber of Commerce and other business organizations are supporting Johnson & Johnson's call for the full Third Circuit to reconsider a ruling that the groups argue could "saddle" companies with investor class-action suits through the misapplication of a recent U.S. Supreme Court ruling. 
- 
									September 22, 2025
									Harvard Beats Suit Over Instructor's Vaccine-Refusal FiringHarvard University beat a suit by a former medical school instructor who claimed he was wrongly fired for refusing to get a COVID-19 vaccine, as a federal judge ruled his dismissal was automatically triggered when he was terminated by a Harvard-affiliated hospital. 
- 
									September 22, 2025
									Mich. Judge Won't Certify Class In Dental Insurer TCPA SuitA Michigan federal judge won't certify a proposed class alleging Solstice Benefits sent unsolicited faxes to customers in violation of the Telephone Consumer Protection Act, finding that determining members of the class would require highly individualized inquiries that would essentially defeat the purpose of a class action. 
- 
									September 22, 2025
									CVS's Omnicare Hits Ch. 11 After $949M FCA JudgmentOmnicare LLC, CVS Health's subsidiary that provides pharmacy services for long-term care facilities, filed for Chapter 11 bankruptcy relief Monday in Texas following a $949 million judgment against Omnicare and CVS issued by a New York federal judge earlier this year. 
- 
									September 22, 2025
									Novant Escapes Black Ex-Lab Worker's Race Bias SuitA North Carolina federal judge tossed a Black lab supervisor's suit claiming hospital system Novant Health cut ties with her because she complained that a cartoon shared at work was racist, saying she hadn't done enough to show the company was motivated by prejudice. 
- 
									September 22, 2025
									Wachtell, Paul Weiss Advise On Pfizer's $7.3B Obesity PathPfizer Inc. will acquire Metsera Inc. for $4.9 billion in cash, as the U.S. pharmaceutical giant bets on the biotech firm's experimental treatments for obesity and cardiometabolic diseases, the companies said Monday. 
- 
									September 22, 2025
									Fla. Marketer Gets 57 Months For $11.5M Medicare FraudA Florida marketer received nearly five years in prison after admitting in Florida federal court to his role in a scheme to defraud the U.S. out of $11.5 million by convincing Medicare beneficiaries to take genetic screen tests that were not medically necessary. 
- 
									September 22, 2025
									Anthem's $12.9M ERISA Deal Clears First HurdleA New York federal judge has granted preliminary approval to a nearly $12.9 million settlement resolving claims that Anthem wrongfully denied coverage for residential behavioral health treatment under employer-sponsored health plans. 
- 
									September 22, 2025
									Mayo Clinic Can't Fully Nix Suit Over Withheld Benefits InfoThe Mayo Clinic and its benefits administrator can't entirely escape a worker's suit claiming they pushed her to work with pricey out-of-network providers and wouldn't provide reimbursement estimates, after a Minnesota federal judge said she supported some federal benefits law claims with enough detail to remain in court. 
- 
									September 22, 2025
									4 Firms Build Patient Square's $2.6B Premier Take-Private DealTechnology-driven healthcare company Premier Inc. on Monday announced plans to go private after being bought by healthcare investment firm Patient Square Capital in a transaction valued at $2.6 billion that was built by four law firms. 
- 
									September 22, 2025
									ProPhase COVID-19 Testing Units Hit Ch. 11 In NJBiotechnology company ProPhase Labs Inc. put three of its COVID-19 laboratory testing subsidiaries in Chapter 11 bankruptcy Monday in New Jersey with combined liabilities of more than $13 million, saying it has been underpaid by insurance companies. 
- 
									September 19, 2025
									Trump Tags H-1B Visa Apps With $100,000 FeePresident Donald Trump on Friday signed an executive order to impose a $100,000 fee for H-1B visas, framing it as a "restriction on entry" necessary to stem the entry of high-skilled foreign workers, particularly in science and technology fields. 
- 
									September 19, 2025
									IBS Drug Buyers Win Class Cert. In Takeda Antitrust CaseA Massachusetts federal judge on Friday certified buyer classes in litigation alleging Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal with Par Pharmaceuticals to keep a generic version of Takeda's anti-constipation drug Amitiza off the market for several years. 
- 
									September 19, 2025
									Ga. Providers Seek Exit From 'Conspiratorial' BCBS Fraud SuitHealthcare consulting firm HaloMD and several providers urged a federal judge Friday to toss a lawsuit from Blue Cross Blue Shield of Georgia accusing them of abusing a federal dispute resolution process for surprise medical bills, arguing the insurer's suit offers little more than "inflammatory, conspiratorial rhetoric." 
- 
									September 19, 2025
									Goodwin, Latham Steer E-Commerce Co. Pattern's $300M IPOTop Amazon.com reseller Pattern Group Inc. kicked off its public-market trading debut on the Nasdaq on Friday with a $300 million initial public offering guided by Goodwin Procter LLP, and Latham & Watkins LLP represented the underwriters, which include Goldman Sachs & Co. LLC and J.P. Morgan. 
- 
									September 19, 2025
									Fla. Court OKs $20M Settlement In Fortra Data Breach MDLA Florida federal judge gave final approval to a $20 million class action settlement as part of multidistrict litigation over theft of personal information from millions of U.S. citizens in a health data breach tied to a Russian ransomware group. 
- 
									September 19, 2025
									Surgery Center Wins Contract Fight With Spine DocA Colorado federal jury Thursday sided with Arete Surgical Centers LLC in a contract fight with a spine surgeon in which each party accused the other of violating a settlement agreement over an earlier dispute, awarding the center just over $300,000. 
- 
									September 19, 2025
									11th Circ. Backs Insurer In Damaged Blood Plasma SuitThe Eleventh Circuit backed an insurer's early win in a coverage dispute over $820,000 in blood plasma that was declared a total loss thanks to a shipping holdup, holding that the "plain language" of its policy clearly excluded claims for delays. 
- 
									September 19, 2025
									Polsinelli Adds ArentFox Schiff Bankruptcy Pro In NYPolsinelli PC has expanded its bankruptcy team in New York with the addition of an attorney from ArentFox Schiff LLP. 
- 
									September 19, 2025
									Rite Aid Gets OK To Seek Votes On Dual-Track Ch. 11 PlanA New Jersey bankruptcy judge on Friday approved drugstore chain Rite Aid's bid to take votes on a Chapter 11 plan as the debtor weighs whether to complete a deal with McKesson Corp. or formally seek to dismiss its bankruptcy case. 
- 
									September 19, 2025
									CDC Panel Urges Caution On COVID Vax, Punts On Hep BA panel of advisers at the Centers for Disease Control and Prevention on Friday voted unanimously to recommend that people receiving the COVID-19 vaccine this season do so only after discussing it with their health providers. 
- 
									September 18, 2025
									Prospect Medical Says It May Drop Stay On Tort CasesCounsel for Prospect Medical Holdings on Thursday told a Texas bankruptcy judge that talks to establish a procedure for handling tort claims in the hospital operator's Chapter 11 case have deadlocked, and it's prepared to let hundreds of tort claimants go back to the courthouse. 
- 
									September 18, 2025
									Ill. Justices Reverse Therapist's Fee Win Against RegulatorIllinois' financial and professional regulator should not be ordered to pay attorney fees in connection with a therapist's successful bid to shield his notes from a doctor's administrative reinstatement hearing, the state's highest court ruled Thursday. 
- 
									September 18, 2025
									Federal Vaccine Panel Votes To Tweak MMRV RecommendationA panel of federal vaccine advisers on Thursday changed its recommendation for a long-used vaccine for children but allowed a key government program to continue paying for the shots. 
- 
									September 18, 2025
									Brothers Blame Associate For $90M HIV Drug Fraud SchemeTwo Maryland brothers accused of selling $90 million worth of mislabeled HIV drugs told a Florida federal jury on Thursday that their charges stem from an associate hired for his pharmaceutical industry connections, but who instead lied about the medication's black market origins and told them it was purchased legitimately. 
Expert Analysis
- 
								
								Medicare Advantage Enforcement Strong Amid Agency Cuts.jpg)  The second Trump administration's actions thus far suggest that Medicare Advantage enforcement remains a bipartisan focus despite challenges presented by evolving trends in federal agency staffing and resources, say attorneys at Ropes & Gray. 
- 
								
								3 Steps For In-House Counsel To Assess Litigation Claims  Before a potential economic downturn, in-house attorneys should investigate whether their company is sitting on hidden litigation claims that could unlock large recoveries to help the business withstand tough times, says Will Burgess at Hilgers Graben. 
- 
								
								A Look At AI Benefits And Risks In Global Development Efforts  In areas like healthcare and law, artificial intelligence can play a transformative role in achieving the U.N.'s 2030 agenda for creating a more equitable, prosperous and sustainable world, but if not properly managed, AI could hinder global development efforts and widen existing gaps within society, say attorneys at Winston & Strawn. 
- 
								
								J&J's Failed 3rd Try Casts Doubt On Use Of 'Texas Two-Step'  A Texas bankruptcy court recently rejected Johnson & Johnson's third attempt to use Chapter 11 to resolve liabilities from allegations of injuries from using talcum powder, suggesting that the U.S. Supreme Court's limitations on nondebtor releases, from 2024's Purdue Pharma ruling, may prove difficult to evade, say attorneys at Cadwalader. 
- 
								Series Teaching College Students Makes Me A Better Lawyer  Serving as an adjunct college professor has taught me the importance of building rapport, communicating effectively, and persuading individuals to critically analyze the difference between what they think and what they know — principles that have helped to improve my practice of law, says Sheria Clarke at Nelson Mullins. 
- 
								
								5 Areas Contractors Should Watch After 1st 100 Days  Federal agencies and contractors face challenges from staff reductions, contract terminations, pending regulatory reform and other actions from the second Trump administration's first 100 days, but other areas stand to become more efficient and cost-effective, say attorneys at Thompson Hine. 
- 
								
								A New Tool For Assessing Kickback Risks In Health Marketing  The Seventh Circuit's recent decision in U.S. v. Sorensen, reversing a conviction after trial of a durable medical equipment distributor, highlights two principle considerations for determining whether payments to marketers in healthcare are unlawful under the Anti-Kickback Statute, says Elisha Kobre at Sheppard Mullin. 
- 
								
								Why Attys Should Get Familiar With Quantum Computing  Quantum computing is projected to pose significant updates to current practices in cryptography, making the issue relevant to policymakers and the legal profession generally, particularly when it comes to data storage, privacy regulations and pharmaceutical industry market changes, say professors at the University of San Francisco. 
- 
								Series Adapting To Private Practice: From DOJ Enviro To Mid-Law  Practitioners leaving a longtime government role for private practice — as when I departed the U.S. Department of Justice’s environmental enforcement division — should prioritize finding a firm that shares their principles, values their experience and will invest in their transition, says John Cruden at Beveridge & Diamond. 
- 
								
								AG Watch: Letitia James' Major Influence On Federal Litigation  While the multistate cases brought by New York Attorney General Letitia James appear to be based upon her interpretation of the effect of the Trump administration's policies on New York state and its residents, most also have a decidedly political tone to them, says Dennis Vacco at Lippes Mathias. 
- 
								
								How Trump Orders Affect Health Orgs.' Care For Trans Minors  Two recent executive orders issued by President Donald Trump regarding gender-affirming care for minors have put healthcare organizations in a precarious situation, and these institutions should prepare for various implications and potential scenarios, say attorneys at ArentFox. 
- 
								
								Legal Ethics Considerations For Law Firm Pro Bono Deals  If a law firm enters into a pro bono deal with the Trump administration in exchange for avoiding or removing an executive order, it has an ethical obligation to create a written settlement agreement with specific terms, which would mitigate some potential conflict of interest problems, says Andrew Altschul at Buchanan Angeli. 
- 
								
								Reproductive Health Under Trump So Far, And What's Next.jpg)  Based on priorities stated so far, the Trump administration will likely continue to weaken Biden-era policies that protect reproductive health, with abortion, in vitro fertilization and contraception all being issues to watch closely amid a post-Dobbs shift, say attorneys at McDermott. 
- 
								Series Playing Football Made Me A Better Lawyer  While my football career ended over 15 years ago, the lessons the sport taught me about grit, accountability and resilience have stayed with me and will continue to help me succeed as an attorney, says Bert McBride at Trenam. 
- 
								
								10 Arbitrations And A 5th Circ. Ruling Flag Arb. Clause Risks  The ongoing arbitral saga of Sullivan v. Feldman, which has engendered proceedings before 10 different arbitrators in Texas and Louisiana along with last month's Fifth Circuit opinion, showcases both the risks and limitations of arbitration clauses in retainer agreements for resolving attorney-client disputes, says Christopher Blazejewski at Sherin and Lodgen.